Recombinant Trichomonas Vaginalis AK Protein (aa 10-229) (Baculovirus) (VAng-Cr8513)
Trichomonas Vaginalis Adenylate kinase (AK), recombinant protein.
Target
Trichomonas Vaginalis
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
Tris-based buffer, 50% glycerol.
Purity
> 85% pure by SDS-PAGE.
Storage
Store at -20°C for short time; store at -20 °C to -80 °C for long time
Introduction
Trichomonas Vaginalis is an anaerobic, flagellated protozoan parasite and the causative agent of trichomoniasis. It is the most common pathogenic protozoan infection of humans in industrialized countries. Infection rates between men and women are similar with women being symptomatic, while infections in men are usually asymptomatic. Transmission usually occurs via direct, skin-to-skin contact with an infected individual, most often through vaginal intercourse. The WHO has estimated that 160 million cases of infection are acquired annually worldwide. The estimates for North America alone are between 5 and 8 million new infections each year, with an estimated rate of asymptomatic cases as high as 50%. Usually treatment consists of metronidazole and tinidazole.
Alternative Names
T. vaginalis
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.